Stock listing
Inhalation Sciences Sweden Ab
Selected listing: ISAB · NGM · SEK · SE
Inhalation Sciences Sweden Ab (NGM:ISAB), Health Technology. Latest release Aug 20, 2026: Inhalation Sciences to present the compelling results…
- Ticker
- NGM:ISAB
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NGM
- Currency
- SEK
About Inhalation Sciences Sweden Ab
Inhalation Sciences Sweden AB, trading under the ticker ISAB, is a public company listed on the Swedish market. It focuses on developing innovative inhalation technologies for pharmaceutical and research applications.
Latest news from Inhalation Sciences Sweden Ab
Inhalation Sciences to present the compelling results from the FDA-funded evaluation study of DissolvIt® at leading respiratory and inhalation drug development conferences
August 20, 2026
Inhalation Sciences receives IRS order worth approximately EUR 117,000
May 18, 2026
ISAB: Revenue and order intake surged, losses narrowed, and acquisition talks are advancing
May 11, 2026
Inhalation Sciences: Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000
March 24, 2026
Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000
March 24, 2026
Research Inhalation Sciences Sweden Ab
Inhalation Sciences Sweden Ab company profile
View the public company page for Inhalation Sciences Sweden Ab on 6ix.
Inhalation Sciences Sweden Ab news
Read company news and market updates connected to Inhalation Sciences Sweden Ab.
Inhalation Sciences Sweden Ab investor events
Find investor webinars, events, and replay context for Inhalation Sciences Sweden Ab.